Mouse-specific tandem IgY7-SuperMix immunoaffinity separations for improved LC-MS/MS coverage of the plasma proteome.

We report on a mouse specific SuperMix immunoaffinity separation system for separating low-abundance proteins from high and moderate abundance proteins in mouse plasma. When applied in tandem with a mouse IgY7 column that removes the seven most abundant proteins in plasma, the SuperMix column captures more than 100 additional moderate abundance proteins, thus allowing significant enrichment of low-abundance proteins in the flow-through fraction. A side-by-side comparison of results obtained from 2D-LC-MS/MS analyses of flow-through samples from IgY7 and SuperMix columns revealed a nearly 2-fold improvement in the overall proteome coverage. Detection of low-abundance proteins was also enhanced, as evidenced by a more than 2-fold increase in the coverage of cytokines, growth factors, and other low-abundance proteins. Moreover, the tandem separations are automated, reproducible, and allow effective identification of protein abundance differences from LC-MS/MS analyses. Considering the overall reproducibility and increased sensitivity using the IgY7-SuperMix separation system, we anticipate broad applications of this strategy for biomarker discovery using mouse models.

[1]  J. Yun,et al.  Plasma proteome analysis for anti‐obesity and anti‐diabetic potentials of chitosan oligosaccharides in ob/ob mice , 2009, Proteomics.

[2]  T. Franke,et al.  PI3K/Akt: getting it right matters , 2008, Oncogene.

[3]  David T. Kaleta,et al.  Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy*S , 2008, Molecular & Cellular Proteomics.

[4]  C. Kemp,et al.  A mouse model repository for cancer biomarker discovery. , 2008, Journal of proteome research.

[5]  Michelle A. Anderson,et al.  A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development , 2008, PLoS medicine.

[6]  S. Hanash,et al.  Mining the plasma proteome for cancer biomarkers , 2008, Nature.

[7]  S. Hanash,et al.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. , 2008, Journal of proteome research.

[8]  Heidi Zhang,et al.  Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. , 2007, Journal of proteome research.

[9]  Timothy D Veenstra,et al.  Serum and plasma proteomics. , 2007, Chemical reviews.

[10]  L. Rodrigues,et al.  The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  Siqi Liu,et al.  The alterations of mouse plasma proteins during septic development. , 2007, Journal of proteome research.

[12]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[13]  Ronald J. Moore,et al.  Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[14]  Richard D. Smith,et al.  Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.

[15]  I. Kohane,et al.  Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. , 2006, Journal of proteome research.

[16]  Fuchu He,et al.  Different immunoaffinity fractionation strategies to characterize the human plasma proteome. , 2006, Journal of proteome research.

[17]  Feng Li,et al.  The mimecan gene expressed in human pituitary and regulated by pituitary transcription factor-1 as a marker for diagnosing pituitary tumors. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  J. Granger,et al.  Albumin depletion of human plasma also removes low abundance proteins including the cytokines , 2005, Proteomics.

[19]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[20]  D. Herold,et al.  Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis , 2005, Proteomics.

[21]  W. Barrett,et al.  Differences among techniques for high‐abundant protein depletion , 2005, Proteomics.

[22]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[23]  N. Anderson,et al.  Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.

[24]  N. Anderson,et al.  The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.

[25]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[26]  J. E. Attrill,et al.  Analytical techniques for cell fractions. XX. Cyclic affinity chromatography: principles and applications. , 1975, Analytical biochemistry.

[27]  Damian Fermin,et al.  Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. , 2009, Cancer research.

[28]  Carol J. Bult,et al.  The mouse as a model for human biology: a resource guide for complex trait analysis , 2007, Nature Reviews Genetics.

[29]  Matthew E Monroe,et al.  Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. , 2005, Journal of proteome research.